139 related articles for article (PubMed ID: 30952752)
41. The relationship between basal and luminal cytokeratins with histopathologic characteristics of canine mammary gland cancer.
Eivani D; Mortazavi P
Pol J Vet Sci; 2016; 19(2):261-9. PubMed ID: 27487499
[TBL] [Abstract][Full Text] [Related]
42. Immunohistochemical Expression of CCR2, CSF1R and MMP9 in Canine Inflammatory Mammary Carcinomas.
Raposo TP; Beirão BC; Pires I; Prada J; Brilhante P; Argyle DJ; Queiroga FL
Anticancer Res; 2016 Apr; 36(4):1805-13. PubMed ID: 27069163
[TBL] [Abstract][Full Text] [Related]
43. Estrogens metabolism associated with polymorphisms: influence of COMT G482a genotype on age at onset of canine mammary tumors.
Dias Pereira P; Lopes CC; Matos AJ; Pinto D; Gärtner F; Lopes C; Medeiros R
Vet Pathol; 2008 Mar; 45(2):124-30. PubMed ID: 18424824
[TBL] [Abstract][Full Text] [Related]
44. Epitheliosis is a histopathological finding associated with malignancy and poor prognosis in dogs with mammary tumors.
Valdivia G; Alonso-Diez Á; Alonso-Miguel D; Suárez M; García P; Ortiz-Díez G; Pérez-Alenza MD; Peña L
Vet Pathol; 2022 Sep; 59(5):747-758. PubMed ID: 35451346
[TBL] [Abstract][Full Text] [Related]
45. Immunohistochemical vascular factor expression in canine inflammatory mammary carcinoma.
Camacho L; Peña L; Gil AG; Martín-Ruiz A; Dunner S; Illera JC
Vet Pathol; 2014 Jul; 51(4):737-48. PubMed ID: 24048323
[TBL] [Abstract][Full Text] [Related]
46. Prognostic value of tumour-associated macrophages in canine mammary tumours.
Raposo T; Gregório H; Pires I; Prada J; Queiroga FL
Vet Comp Oncol; 2014 Mar; 12(1):10-9. PubMed ID: 22533625
[TBL] [Abstract][Full Text] [Related]
47. EGFR and microvessel density in canine malignant mammary tumours.
Carvalho MI; Guimarães MJ; Pires I; Prada J; Silva-Carvalho R; Lopes C; Queiroga FL
Res Vet Sci; 2013 Dec; 95(3):1094-9. PubMed ID: 24091029
[TBL] [Abstract][Full Text] [Related]
48. Expression of autophagy-related protein Beclin-1 in malignant canine mammary tumors.
Liu JL; Chang KC; Lo CC; Chu PY; Liu CH
BMC Vet Res; 2013 Apr; 9():75. PubMed ID: 23578251
[TBL] [Abstract][Full Text] [Related]
49. Thyroglobulin as a negative marker for malignancy in canine and human breast tumors.
Hwang SH; Yang Y; Woo SH; Jung JH; Seo D; Kim DY; Kim Y
Mol Carcinog; 2021 Jul; 60(7):455-468. PubMed ID: 34003526
[TBL] [Abstract][Full Text] [Related]
50. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues.
Gama A; Gärtner F; Alves A; Schmitt F
Res Vet Sci; 2009 Dec; 87(3):432-7. PubMed ID: 19464036
[TBL] [Abstract][Full Text] [Related]
51. Risk factor analysis and clinicopathological characteristics of female dogs with mammary tumours from a single-center retrospective study in Poland.
Dolka I; Czopowicz M; Stopka D; Wojtkowska A; Kaszak I; Sapierzyński R
Sci Rep; 2024 Mar; 14(1):5569. PubMed ID: 38448646
[TBL] [Abstract][Full Text] [Related]
52. The Expression of Selected Factors Related to T Lymphocyte Activity in Canine Mammary Tumors.
Bujak JK; Szopa IM; Pingwara R; Kruczyk O; Krzemińska N; Mucha J; Majchrzak-Kuligowska K
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32225066
[TBL] [Abstract][Full Text] [Related]
53. Expression and significance of PTEN in canine mammary gland tumours.
Qiu C; Lin D; Wang J; Wang L
Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231
[TBL] [Abstract][Full Text] [Related]
54. Expression and significance of CHIP in canine mammary gland tumors.
Wang H; Yang X; Jin Y; Pei S; Zhang D; Ma W; Huang J; Qiu H; Zhang X; Jiang Q; Sun W; Zhang H; Lin D
J Vet Med Sci; 2015 Nov; 77(11):1465-71. PubMed ID: 26156079
[TBL] [Abstract][Full Text] [Related]
55. Overexpression of α-enolase correlates with poor survival in canine mammary carcinoma.
Chu PY; Hsu NC; Liao AT; Shih NY; Hou MF; Liu CH
BMC Vet Res; 2011 Oct; 7():62. PubMed ID: 22014164
[TBL] [Abstract][Full Text] [Related]
56. Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics.
Peña L; De Andrés PJ; Clemente M; Cuesta P; Pérez-Alenza MD
Vet Pathol; 2013 Jan; 50(1):94-105. PubMed ID: 22688585
[TBL] [Abstract][Full Text] [Related]
57. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.
Pinho SS; Matos AJ; Lopes C; Marcos NT; Carvalheira J; Reis CA; Gärtner F
BMC Cancer; 2007 Jul; 7():124. PubMed ID: 17617904
[TBL] [Abstract][Full Text] [Related]
58. Five markers useful for the distinction of canine mammary malignancy.
Pawłowski KM; Maciejewski H; Majchrzak K; Dolka I; Mol JA; Motyl T; Król M
BMC Vet Res; 2013 Jul; 9():138. PubMed ID: 23844591
[TBL] [Abstract][Full Text] [Related]
59. Expression of iNOS, COX-2 and VEGF in canine mammary tumours and non-neoplastic mammary glands: Association with clinicopathological features and tumour grade.
Anadol E; Yar Saglam AS; Gultiken N; Karakas K; Alcigir E; Alkan H; Kanca H
Acta Vet Hung; 2017 Sep; 65(3):382-393. PubMed ID: 28956485
[TBL] [Abstract][Full Text] [Related]
60. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
